SciSparc unit NeuroThera Labs wins Japanese patent for paracetamol combination therapy
SPRC•Japanese patent covers paracetamol combination platform
SciSparc unit NeuroThera Labs secured a Japanese patent covering a proprietary drug-combination platform aimed at enhancing paracetamol-class therapies.
The patent covers compositions pairing 4-aminophenol derivatives with N-acylethanolamines to boost analgesic and antipyretic performance.
NeuroThera said it targets lower effective dosing to reduce dose-related side-effect risk, strengthening its intellectual property position in Japan.
